Related Experiment Videos
A parametric survival model with an interval-censored covariate
Klaus Langohr1, Guadalupe Gómez, Robert Muga
1Departament d'Estadística i Investigació Operativa, Universitat Politècnica de Catalunya, Pau Gargallo 5, 08028 Barcelona, Spain. klaus.langohr@upc.es
Statistics in Medicine
|September 28, 2004
Summary
This study introduces a new survival model for interval-censored data, analyzing the link between injecting drug use, HIV infection, and AIDS incubation periods in a Spanish cohort.
Area of Science:
- Biostatistics
- Epidemiology
- Survival Analysis
Background:
- Injecting drug use is a significant risk factor for Human Immunodeficiency Virus (HIV) infection.
- HIV infection can lead to Acquired Immunodeficiency Syndrome (AIDS), a critical stage of the disease.
- Understanding the time intervals between these events is crucial for public health interventions.
Purpose of the Study:
- To develop and apply a parametric survival model incorporating interval-censored covariates.
- To investigate the association between the time from first injecting drug use to HIV infection and the subsequent AIDS incubation period.
- To analyze data from a cohort of injecting drug users in Badalona, Spain.
Main Methods:
- Development of a novel parametric survival model.
- Inclusion of an interval-censored covariate representing the time to HIV infection.
- Utilizing a numerical solver and the AMPL mathematical programming language for likelihood function maximization.
- Handling doubly-censored data for time until AIDS onset.
Main Results:
- The study successfully implemented a specialized survival model for complex time-to-event data.
- The model allowed for the analysis of associations where key events are not precisely observed.
- Numerical optimization techniques were effective in maximizing the likelihood function.
Conclusions:
- The proposed parametric survival model is suitable for analyzing interval-censored data in epidemiological studies.
- The methodology provides a framework for understanding disease progression in populations with risk factors like injecting drug use.
- Further application of this model can enhance insights into HIV/AIDS natural history and inform prevention strategies.